Literature DB >> 30239720

Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation.

Daniele Bottai1, Marco Spreafico2, Anna Pistocchi2, Grazia Fazio3, Raffaella Adami1, Paolo Grazioli1, Adriana Canu2, Cinzia Bragato4,5, Silvia Rigamonti1,3, Chiara Parodi1, Gianni Cazzaniga3, Andrea Biondi6, Franco Cotelli7, Angelo Selicorni8, Valentina Massa1.   

Abstract

Cornelia de Lange syndrome (CdLS), which is reported to affect ∼1 in 10 000 to 30 000 newborns, is a multisystem organ developmental disorder with relatively mild to severe effects. Among others, intellectual disability represents an important feature of this condition. CdLS can result from mutations in at least five genes: nipped-B-like protein, structural maintenance of chromosomes 1A, structural maintenance of chromosomes 3, RAD21 cohesin complex component and histone deacetylase 8 (HDAC8). It is believed that mutations in these genes cause CdLS by impairing the function of the cohesin complex (to which all the aforementioned genes contribute to the structure or function), disrupting gene regulation during critical stages of early development. Since intellectual disorder might result from alterations in neural development, in this work, we studied the role of Hdac8 gene in mouse neural stem cells (NSCs) and in vertebrate (Danio rerio) brain development by knockdown and chemical inhibition experiments. Underlying features of Hdac8 deficiency is an increased cell death in the developing neural tissues, either in mouse NSCs or in zebrafish embryos.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30239720     DOI: 10.1093/hmg/ddy329

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

Review 1.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 2.  S-adenosylmethionine tRNA modification: unexpected/unsuspected implications of former/new players.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Int J Biol Sci       Date:  2020-09-30       Impact factor: 6.580

3.  Lithium as a possible therapeutic strategy for Cornelia de Lange syndrome.

Authors:  Paolo Grazioli; Chiara Parodi; Milena Mariani; Daniele Bottai; Elisabetta Di Fede; Aida Zulueta; Laura Avagliano; Anna Cereda; Romano Tenconi; Jolanta Wierzba; Raffaella Adami; Maria Iascone; Paola Francesca Ajmone; Thomas Vaccari; Cristina Gervasini; Angelo Selicorni; Valentina Massa
Journal:  Cell Death Discov       Date:  2021-02-17

4.  Cohesin Mutations Induce Chromatin Conformation Perturbation of the H19/IGF2 Imprinted Region and Gene Expression Dysregulation in Cornelia de Lange Syndrome Cell Lines.

Authors:  Silvana Pileggi; Marta La Vecchia; Elisa Adele Colombo; Laura Fontana; Patrizia Colapietro; Davide Rovina; Annamaria Morotti; Silvia Tabano; Giovanni Porta; Myriam Alcalay; Cristina Gervasini; Monica Miozzo; Silvia Maria Sirchia
Journal:  Biomolecules       Date:  2021-11-02

5.  Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients.

Authors:  Carlotta Pipolo; Daniele Bottai; Emanuela Fuccillo; Eleonora Aronica; Fabio Bruschi; Antonio Mario Bulfamante; Luca Castellani; Maria Paola Canevini; Davide Chiumello; Sergio Ferrari; Carla Martinelli; Stefano Muttini; Alberto Priori; Alberto Maria Saibene; Chiara Spoldi; Delfina Tosi; Gianluigi Zanusso; Gaetano Pietro Bulfamante; Giovanni Felisati
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

6.  Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.

Authors:  Alessandro Umbach; Giulia Maule; Eyemen Kheir; Alessandro Cutarelli; Marika Foglia; Luca Guarrera; Luca L Fava; Luciano Conti; Enrico Garattini; Mineko Terao; Anna Cereseto
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.